You are here : Home > The Institute > News > A new generation of nanovectors for anticancer therapies.

Scientific result | Chemistry | Nanosciences | Nanomedicine

A new generation of nanovectors for anticancer therapies.

​As part of a collaboration with MIRCen (Jacob Institute), researchers of SCBM have developed functional micellar vectors that can effectively target tumors and whose therapeutic activity is intrinsically carried by the constitutive unit of the micelle. This combination leads to better drug load and avoids premature drug release.

Published on 12 June 2019

Abstract of the original paper

Micelle-forming amphiphilic drug conjugates were synthesized starting from a biologically active epipodophyllotoxin derivative which was covalently inserted in between a hydrophilic PEG unit and a hydrophobic stearyl chain. The epipodophyllotoxin-containing amphiphiles were assembled into the corresponding micelles which were evaluated in vivo for their tumor targeting properties.

Top page